Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination. Issue 1 (19th May 2022)

Record Type:: Journal Article
Title:: Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination. Issue 1 (19th May 2022)
Main Title:: Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination
Authors:: Fagni, Filippo
Schmidt, Katja
Bohr, Daniela
Valor-Méndez, Larissa
Hartmann, Fabian
Tascilar, Koray
Manger, Karin
Manger, Bernhard
Kleyer, Arnd
Simon, David
Schett, Georg
Harrer, Thomas
Abstract:
Is Part Of:: RMD open. Volume 8:Issue 1(2022)
Journal:: RMD open
Issue:: Volume 8:Issue 1(2022)
Issue Display:: Volume 8, Issue 1 (2022)
Year:: 2022
Volume:: 8
Issue:: 1
Issue Sort Value:: 2022-0008-0001-0000
Page Start:
Page End:
Publication Date:: 2022-05-19
Subjects:: COVID-19 -- Vaccination -- Rituximab -- Autoimmune Diseases -- Epidemiology
Musculoskeletal system -- Diseases -- Periodicals
Rheumatism -- Periodicals
616.7005
Journal URLs:: http://www.bmj.com/archive ↗
http://rmdopen.bmj.com/ ↗
DOI:: 10.1136/rmdopen-2022-002323 ↗
Languages:: English
ISSNs:: 2056-5933
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21496.xml